Hide Board Information

Show Board Information

ASLAN Pharmaceuticals Limited ASLN

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/04/2023 4:08:32 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) Stock Message Board

1. ASLN Company Profile

    

2. ASLN Time & Sales

    

3. ASLN Recent News

    

4. ASLN Filings

    

5. ASLN Financials

    

6. ASLN Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	$ASLN 37% v735K c.5984 f69,744M H.65	znewcar1	01/04/2023 4:08:32 PM
4	ASLN 18% v52,1M c5.25 f37,9M preMH8.16 HOD6.75	znewcar1	03/01/2021 4:28:52 PM
3	ASLN 26% v12,4M c4.46 f37,9M H5.49 gap dipNgo to	znewcar1	02/25/2021 4:12:29 PM
2	ASLN could get interesting IMO with 20M in vol.	znewcar1	01/22/2020 12:32:44 PM
1	ASLN 36% v15M c5.20 f32M H 8.18 gap up & over	znewcar1	12/02/2019 10:59:48 PM

Recent Articles

• Governance Issues Emerge as Wise Moves to U.S. Listing
• Insightful Trends in ETH and SOL Revealed by Bybit Analysis
• Inspire Advisors Celebrated as Leading RIA Firm for 2025
• Yanfeng's 2024 ESG Report: Innovations in Sustainable Practices
• Corporate Finance Institute: Leading FP&A Certification Insights
• DeepRoute.ai Shines with IDC 2025 Assisted Driving Assessment
• Mitto Scores Prestigious Spot in 2025 CPaaS Magic Quadrant
• Join Global Innovators at the FHC Shanghai Beverage Expo
• LONGi Hi-MO 9 Ice-Shield Modules: Pioneering Solar Safety
• Key Insights for Investors as Fed Decisions Loom Ahead
• Industrial Stocks Surge as Big Tech Loses Its Dominance
• Powell's Press Conference: All Eyes on Future Rate Decisions
• HTX Introduces Innovative Crypto Gifts and Exciting Prizes
• Enhancing AI with Aurora Mobile and Zhipu AI Integration
• Madrigal Pharmaceuticals Strikes Global License for SYH2086
• Check Point Software Achieves Impressive Q2 2025 Growth
• Key Transactions by Corporate Leaders at Danske Bank Revealed
• Call for Action Against Starlink Utilization by Scammers
• Zuckerberg's AI Ambitions: Targeting Top Talent Amidst Controversy
• New Oriental's Fiscal Year 2025 Financial Performance Review
• Check Point Software Reveals Strong Q2 2025 Financial Results
• New Oriental's Strong Q4 Results Reflect Growth and Strategy
• Innovative Partnership Enhances Access to Oncology Insights Globally
• Global Seed Treatment Market Analysis and Future Trends
• Navigating Summer Spending: Tips to Stay Financially Smart
• Unleashing Adventure: Jurassic World Experience with Prezzee
• Innovative Business Growth Solutions for 2025: QuickBooks
• Opendoor's Stock Volatility in Focus: What Investors Should Know
• RD Technologies Raises $40 Million to Propel Fintech Innovations
• TECO Electric and Foxconn Forge Alliance for AI Data Centers
• Exploring New Frontiers at FHC Shanghai Global Food Show
• Scott Bessent Highlights Trump's Role in US-China Trade Talks
• Starbucks Thrives Under Leadership of Brian Niccol Amid Changes
• Exploring the Growing Market for Lenacapavir Injections
• Overview of BofA Securities Europe SA Shareholding Changes
• Understanding Public Disclosure by Apax Global Alpha Limited
• Festi hf. Reports Strong Performance in Q2 2025 Financial Results
• Understanding Exempt Principal Trader Dealings in NCC Group
• Recent Trading Disclosures by Dowlais Group Plc and Investec Bank
• Festi hf. Unveils Second Quarter 2025 Financial Highlights
• Foxconn and TECO Forge Alliance to Transform AI Data Centers
• Revolutionizing Industries: The Rise of Intelligent Robots
• Foxconn and TECO Forge Strategic Alliance for AI Data Centers
• HBX Group Reports Strong Q3 Results, Growth Strategy in Place
• Strategic Alliance to Advance Innovative Therapies for IBD
• Unlocking the Future of Real-Time Clock ICs in Tech Growth
• FG Nexus Inc. Moves Forward with $200M Placement Strategy
• Rakovina and UBC Foster Innovation in Cancer Treatment
• Atos Achieves Fifth Time Recognition as CDP Supplier Leader
• Key Developments in the Strategic Review of Octopus Titan VCT